Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
Recruiting now · Not applicable
Conditions studied: Alcohol Use Disorder, Cannabis Use Disorder
In brief
This 2-arm study will recruit participants with 1) alcohol use disorder and 2) cannabis use disorder for a 12-week cognitive behavioral therapy, following a thorough baseline assessments on executive function, incentive salience, and negative emotionality.
Key facts
- Study ID
- NCT05855668
- Run by
- Centre for Addiction and Mental Health
- People needed
- 400
- Starts
- 2022-11-10
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-03-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient has been referred to or intends to participate in either the AUD or CUD Integrated Care Pathway (and is therefore willing to participate in group psychotherapy).
- Able to communicate and provide informed consent in English.
- 18 years of age or older.
- Willing and able to safely abstain from substances (other than nicotine or tobacco products), including alcohol and cannabis, for 12 hours prior to the eligibility and task-based assessments.
- Meets DSM-5 diagnostic criteria for AUD (AUD group) or CUD (CUD group)
- Meets criteria for risky drinking, defined as > 10 drinks per week for females and > 15 drinks per week for males on average over the past 30 days (AUD group) or daily or near-daily cannabis use over the past 30 days, defined as ≥ 4 days of cannabis use per week on average (CUD group)
You may not qualify if…
- Active suicidal ideation at time of assessment.
- Suicide attempt within the past month.
- Unstable psychiatric or medical status (e.g., acute psychosis or mania) or unstable use of another substance that may interfere with participation in groups (e.g. active fentanyl use).
- Enrollment in another study that conflicts with the procedures or scientific integrity of this study.
- Individuals planning to be out of the province for a substantial amount of time during the treatment period will not be permitted to enroll.
Where it is running
- Centre for Addiction and Mental Health — Toronto, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.